The Relationship Between FEV 1 and Peak Expiratory Flow in Patients With Airways Obstruction Is Poor*
|
|
- Cecily Lloyd
- 6 years ago
- Views:
Transcription
1 Original Research PULMONARY FUNCTION TESTING The Relationship Between FEV 1 and Peak Expiratory Flow in Patients With Airways Obstruction Is Poor* Ashutosh N. Aggarwal, MD, FCCP; Dheeraj Gupta, MD, FCCP; and Surinder K. Jindal, MD, FCCP Study objectives: To evaluate the correlation between FEV 1 and peak expiratory flow (PEF) values expressed as a percentage of their predicted value, and to assess factors influencing differences between the two measurements. Design: Cross-sectional. Setting: Pulmonary function laboratory at a tertiary-level teaching hospital in northern India. Participants: A total of 6,167 adult patients showing obstructive pattern on spirometry over a 6-year period. Interventions: None. Measurements and results: There was considerable variability between percentage of predicted FEV 1 (FEV 1 %) and percentage of predicted PEF (PEF%). Locally weighted least-square modeling revealed that PEF% overestimated FEV 1 % in patients with less severe obstruction and underestimated it in those with more severe obstruction. Using Bland-Altman analysis, PEF% underestimated FEV 1 % by a mean of only 0.7%; however, limits of agreement were wide ( 27.4 to 28.8%), indicating that these two measurements cannot be used interchangeably. PEF% and FEV 1 % were > 5% apart in approximately three fourths and differed by > 10% in approximately one half of the patients. On multivariate analysis, discordance > 5% was significantly influenced by female gender (odds ratio, 1.26; 95% confidence interval [CI], 1.01 to 1.58) and increasing FEV 1 % (odds ratio, 1.09 for every 10% increase; 95% CI, 1.04 to 1.14) but not by height or age. Conclusions: FEV 1 % and PEF% are not equivalent in many patients, especially women and those with less severe airflow limitation. Assumptions of parity between PEF% and FEV 1 % must be avoided. (CHEST 2006; 130: ) Key words: agreement; airflow limitation; respiratory function tests Abbreviations: CI confidence interval; FEV 1 % percentage of predicted FEV 1 ; PEF peak expiratory flow; PEF% percentage of predicted peak expiratory flow; VC vital capacity *From the Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. The authors have no conflicts of interest to disclose. Manuscript received November 16, 2005; revision accepted April 13, Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( org/misc/reprints.shtml). Correspondence to: Surinder K. Jindal, MD, FCCP, Professor and Head, Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh , India; skjindal@indiachest.org DOI: /chest Spirometry is the recommended investigation for diagnosis and categorization of severity of airflow limitation. 1 Spirometry is a well-standardized technique, and elaborate guidelines already exist regarding procedure performance, evaluation of test quality, and interpretation of measured parameters. 1 3 However, spirometry is not widely available, and the pitfalls of spirometry frequently limit use of this test at the primary care level. 4,5 Peak expiratory flow (PEF) recording is proposed as an alternative to spirometry for this purpose. 6 8 The PEF instrument is cheap, portable, and easy to operate and maintain. Guidelines 9 11 on asthma management focus heavily on categorizing patients based on severity of airflow limitation measured on formal pulmonary function testing. It is suggested that either FEV 1 or PEF can be expressed as a percentage of predicted 1454 Original Research
2 values and used for this purpose. Similarly, definition and severity assessment of COPD is now based on measurement of percentage of predicted FEV 1 (FEV 1 %) and FEV 1 /vital capacity (VC), although a need for evaluating the role of PEF in situations and areas where spirometry is not routinely available is recognized. 12,13 There is, however, no consensus on whether or not FEV 1 % and percentage of predicted PEF (PEF%) can be used interchangeably in patients with obstructive lung diseases. Most clinicians assume a general parity between these measurements, and some guidelines 9,11 on asthma management also recommend the same. However, other guidelines 11,12 also suggest that PEF% may underestimate the degree of airways obstruction assessed by FEV 1 %. Previous studies 8,14 19 addressing comparisons between FEV 1 % and PEF% have been performed in highly selected patients and have been limited to some extent by inclusion of small number of subjects and inability to examine relationships in different subgroups of patients. We therefore studied adult patients with obstructive ventilatory defects from a large spirometry database to evaluate the correlation between FEV 1 % and PEF%, and to assess the factors influencing differences between the two measurements. North Indian adults. 20,21 The regression equations for spirometric indexes were generated from studies performed on 962 healthy nonsmoking North Indian adults, aged 15 to 74 years, using a water seal spirometer. The regression equations for PEF were derived from measurements performed on 3,166 healthy nonsmoking North Indian adults, aged 20 years, using a Wright peak flowmeter. Both these sets of regression equations predict lung function parameters using formulae containing gender, height, and age as variables (Table 1). A spirometry record with FEV 1 /VC ratio less than its predicted lower limit of normal was categorized as having an obstructive defect. The lower limit of normal for FEV 1 /VC ratio was computed by subtracting times the SE of estimate of the corresponding equation from the predicted value. To minimize analysis bias related to multiple records showing obstructive defects in the same individual because of repeated pulmonary function testing, only the first record was retained for further analysis in such situations. Wherever available, postbronchodilator values were chosen for interpretation of spirometry. Observed values for both FEV 1 and PEF were expressed as percentages of predicted values. A simple scatterplot was constructed to assess how closely PEF% approximated FEV 1 %. Iterative locally weighted smoothing techniques were applied to this distribution to obtain a regression curve fitting this data; such a method avoids the undue influence of outlying values on curve estimation by assigning a relatively lesser weight to these values. 22 In order to evaluate if PEF and FEV 1 could be used interchangeably across different categories of age, height, gender, and severity of airway obstruction, we calculated the limits of agreement between the two estimates using Bland-Altman analysis. 23 Multiple logistic regression analysis was also performed to study factors responsible for FEV 1 % and PEF% values being 5% apart from each other. Materials and Methods Our laboratory provides facilities for spirometry and other detailed investigations (such as estimation of static lung volumes, diffusion testing, and study of pulmonary and airway mechanics). Patients are referred for lung function testing not only from our department but also from other medical and surgical specialties of our hospital. Since our institute is a tertiary academic center in northern India, patients are referred for diagnosis and management from several northern Indian states. Records of all consecutive adult patients (aged 15 years) undergoing spirometry during a 6-year period were retrieved. Sources of referral, reasons for performing spirometry, as well as other clinical details were, however, not analyzed further. All subjects performed spirometry on a dry rolling seal spirometer (Spiroflow; P K Morgan Ltd; Kent, UK), followed by PEF estimation using a Wright peak flowmeter. VC, FEV 1, and PEF were measured using American Thoracic Society guidelines, and the highest measurements from among three technically acceptable and reproducible maneuvers were expressed at body temperature and pressure saturated with water vapor. 3 All technicians performing spirometry were experienced in pulmonary function testing and strictly followed standard procedures while analyzing the kymograph output. The spirometer was frequently calibrated to ensure optimum performance. Since the study was a retrospective analysis of already available laboratory records, and patient confidentiality was not breached in any fashion, prior approval from our Hospital Ethics Committee was not required. Age, gender, height, and spirometric data were recorded for all patients using software previously developed by us. 20 The predicted values for VC, FEV 1, FEV 1 /VC ratio, and PEF were generated using previously defined prediction equations for Results During the study period, 25,914 spirometry procedures were performed. After excluding 775 individuals 15 years old and 302 incomplete records, 24,837 records were retained. Of these, 7,395 records (29.8%) were interpreted as having obstructive defect. After excluding 1,228 repeat procedures, 6,167 records formed the database for further analysis. There were 3,213 men (52.1%) aged 16 to 95 years (median, 53 years; interquartile range, 41 to 64 years) and 136 to 189 cm in height (median height, Table 1 Prediction Equations for Lung Function in Healthy North Indian Adults* Parameters Regression Equation Formula SEE Men FEV 1,L A A H FEV 1 /FVC A A H 6.6 PEF A 0.08 A H 55.0 Women FEV A A H FEV 1 /FVC A A H 5.8 PEF A 0.04 A H 51.0 *A age in years; H height in centimeters; SEE standard error of estimate. CHEST / 130 / 5/ NOVEMBER,
3 165 cm; interquartile range, 161 to 170 cm); and 2,954 women (47.9%) aged 16 to 94 years (median, 47 years; interquartile range, 36 to 60 years) and 136 to 189 cm in height (median height, 153 cm; interquartile range, 149 to 157 cm). PEF was reduced in 4,935 patients (80.0%). In general, there was a moderate correlation between FEV 1 % and PEF%, with overall Pearson correlation coefficients of (p 0.001) and (p 0.001) among men and women, respectively. However, the scatter was wide, more so in patients with mild obstruction (Fig 1). The regression curve generated using iterative locally weighted smoothing techniques showed two zones. In patients with FEV 1 % 40%, PEF% tended to underestimate FEV 1 %; in patients with more severe obstruction, PEF% tended to overestimate FEV 1 % (Fig 1). Agreement between FEV 1 % and PEF% was only fair, with weighted estimate of using 10% categories for both FEV 1 % and PEF%. Using arbitrary severity categories based on 20% FEV 1 %intervals, PEF% and FEV 1 % severity categories were concordant in only 3,013 instances (48.9%), with better concordance as severity of obstruction (based on FEV 1 %) became more severe (Table 2). The differences between FEV 1 % and PEF% followed a normal distribution (Fig 2); for the entire study population, PEF% underestimated FEV 1 % by a mean of only 0.7%. However, limits of agreement were wide and exceeded 25% (Fig 3). Overall, differences were more marked in women and in patients at extremes of height distribution (Table 3). PEF% and FEV 1 % were 5% apart in 4,574 patients (74.2%) and 10% apart in 3,161 patients (51.3%). Although there is no consensus on the issue, a discordance 5% could be considered a clinically important error for estimation of severity of airway obstruction. On univariate analysis, the proportion of such discordant results was significantly more in women, and increased significantly with worsening FEV 1 %, and decreasing height (Table 4). On multivariate analysis, gender and FEV 1 % independently influenced discordance (Table 4). Figure 1. Scatterplot showing relationship between FEV 1 and PEF readings referenced to their respective predicted values. The regression curve is fitted using iterative locally weighted smoothing techniques Original Research
4 Table 2 Concordance Between Categorization of Severity of Airway Obstruction Based on FEV 1 % and PEF%* FEV 1 % PEF% 0 to 40% 40 to 60% 60 to 80% 80 to 100% 100% 0 to 40% 897 (75.6) 521 (29.6) 117 (6.7) 13 (1.2) 40 to 60% 254 (21.4) 881 (50.1) 618 (35.2) 164 (14.9) 16 (4.4) 60 to 80% 33 (2.8) 296 (16.8) 744 (42.4) 415 (37.7) 95 (25.9) 80 to 100% 3 (0.3) 48 (2.7) 246 (14.0) 394 (35.8) 159 (43.3) 100% 12 (0.7) 30 (1.7) 114 (10.4) 97 (26.4) *Data are presented as No. (%). Discussion In patients with obstructive lung diseases, both FEV 1 % and PEF% are widely used to estimate the degree of pulmonary impairment. In general, FEV 1 measurements are preferred as these are much more reproducible. However, spirometry is not widely available in developing countries such as India, and there is a need to assess if similar information could be acquired using PEF measurements, which are cheaper and much more widely available. Since clinical decisions are often based on the results of these measurements, we attempted to compare their utility in defining severity of airflow obstruction. A few investigators 14 17,19 have looked at correlation between PEF and FEV 1 in cross-sectional studies. The correlation between absolute values of PEF and FEV 1 values was rather low in one study. 14 In general, the correlation between PEF% and FEV 1 % has been moderate, with correlation coefficients ranging from 0.5 to ,17,19 In our own database, there was a moderate correlation between FEV 1 % and PEF%. In one follow-up study, 15 individual correlation coefficients were found to range from 0.68 to However, a numerical summary of information does not imply that PEF can be used as a surrogate Figure 2. Histogram showing the near-normal distribution of differences between FEV 1 and PEF values. Both are described as a percentage of their respective predicted values, and the latter is subtracted from the former to compute the difference. A discrepancy of 10% between FEV 1 % and PEF% occurred in more than one half of instances. CHEST / 130 / 5/ NOVEMBER,
5 Figure 3. Bland-Altman plot highlighting magnitude of difference between FEV 1 and PEF values expressed as a percentage of their respective predicted values. Horizontal dashed lines represent the mean bias and its 95% confidence limits. for FEV 1. Scatterplots from various reports show considerable difference in FEV 1 % and PEF% values in individual patients, although most coordinates lie close to the line of identity. To avoid undue influence from outlying values, we used iterative locally weighted smoothing to obtain a regression curve fitting our data; and we found that in patients with severe airway obstruction (FEV 1 40% of predicted), PEF% overestimated FEV 1 %, whereas exactly the opposite happened in patients with less Table 3 Mean Bias and Limits of Agreement Between PEF% and FEV 1 % in the Study Population Men Women Total Variables Bias Limits of Agreement Bias Limits of Agreement Bias Limits of Agreement Age, yr to to to to to to to to to to to to to to to to to to 28.5 Height, cm to to to to to to to to to to to to to to 17.2 Severity of obstruction FEV 1 % 60% to to to 35.0 FEV 1 %40to60% to to to 28.7 FEV 1 % 40% to to to 19.4 Total to to to 28.8 *Bias mean of (FEV 1 % PEF%); Limits of agreement bias (1.96 SD of bias). For details on method of calculation of bias and limits of agreement, see Bland and Altman Original Research
6 Table 4 Results of Logistic Regression Analysis To Study Factors Responsible for Patients Having FEV 1 % and PEF% Values > 5% Apart From Each Other Univariate Analysis Multivariate Analysis Variables Odds Ratio 95% CI Odds Ratio 95% CI Women 1.4* Height (10-cm intervals) 0.9* Age (10-yr intervals) FEV 1 % (10% intervals) 1.1* * *p p severe airway obstruction. Previous investigators 14 have also noted similar trends. In one study, 18 PEF% values were higher than corresponding FEV 1 % values, particularly in patients with moderate-to-severe asthma. In another study, 16 most patients could generate higher PEF% values than FEV 1 % values, although very few patients had severe airway obstruction. Overall, PEF% and FEV 1 % were 5% apart in 74.2% and 10% apart in 51.3% of patients in our data set. Thus, only a minority of patients had PEF% and FEV 1 % values close to each other (Fig 2). Data from previous studies 8,17,18,24,25 also show that limits of agreement are wide and point toward absence of parity between FEV 1 % and PEF% values. In our own data set, limits of agreement were 27.4 to This means that for a given value of PEF%, corresponding FEV 1 % could be 28.8% lower or 27.4% higher. These values render substitution of PEF% for FEV 1 % useless in routine clinical practice. Our results are at slight variance with observations in other reports. The mean difference between FEV 1 % and PEF% in this study was only 0.7%. Previous studies 8,17,18 have shown a much wider mean difference, with FEV 1 % being lower than PEF% by 9.1 to 17.2%. This possibly is related to the selection and size of study populations enrolled in these studies. Most of these studies 8,17,18 included small number of patients (25 to 101 patients). Some studies 8,15,18 recorded multiple paired observations on each subject and analyzed each pair as a separate unit. Both factors preclude generalization of results. Some studies 8,15,16,18 also included patients who, although suffering from an obstructive lung disease, did not have airflow limitation at time of evaluation. As discussed earlier, PEF% in these subjects is likely to be much greater than FEV 1 % in comparison to patients having more severe airway obstruction at time of evaluation, and it is difficult to generalize these results while categorizing severity of airway obstruction. There could be several reasons for lack of equivalence between FEV 1 % and PEF%. 26 For one, measured PEF values depend heavily on lung volumes. Any disease process leading to reduced lung volumes will effect a corresponding reduction in measured PEF. This implies that in addition to patients with airway obstruction, those with restrictive lung defects are also likely to have a reduced PEF. Secondly, normal population variability of PEF is quite large. Hence calculation of lower limits of predicted normal based on regression equations leads to values that are much lower than corresponding values for other spirometric indexes like FEV 1. Thirdly, while PEF is measured on the first effortdependent portion of the forced expiratory maneuver and predominantly reflects large airway function, FEV 1 is determined both by the effort-dependent and effort-independent portions of this maneuver and reflects both large and peripheral airway function. 27 Thus differential changes in FEV 1 and PEF may be observed, depending on the amount and predominant site of airways narrowing. These factors are likely to lead to a greater discrepancy in patients with COPD and airway collapsibility secondary to the loss of elastic tissue. In these patients, the initial rapid rise in expiratory flow is similar but, as intrathoracic pressure increases, that pressure is transmitted to the segmental and other large airways, which collapse and obstruct passage of air through those airways. This results in the rapid reduction in flow after a relatively normal peak has been attained, leading to significantly lower values of FEV 1 compared to PEF. These issues could lead to a significant discordance if FEV 1 % values are replaced by PEF% values for purpose of severity classification. As it is, there is no clearly defined objective strategy to categorize severity of airflow limitation based on FEV 1 % values. Various guidelines on management of asthma and COPD use arbitrary standards for this purpose, adding to the confusion. The FEV 1 % cutoffs used to categorize mild, moderate, and severe obstruction are variable for Global Initiative for Chronic Obstructive Lung Disease (80% and 30%), British CHEST / 130 / 5/ NOVEMBER,
7 Thoracic Society (60% and 40%), American Thoracic Society (50% and 35%), European Respiratory Society (70% and 50%) and new American Thoracic Society/European Respiratory Society (80% and 50%) guidelines on COPD. 12,13,28 30 Both Global Initiative for Asthma and National Institutes of Health guidelines on asthma use FEV 1 % cutoffs of 80% and 60%. 9,11 In the absence of any standard severity classification, we used arbitrary severity groups based on FEV 1 % values and have shown that less than one half the subjects were correctly classified if PEF% replaces FEV 1 % values (Table 2). In addition, there are other technical issues related to equipment. Several PEF meters do not show linear responses, with different proportional error at different flow levels. 31 Significant decrease in accuracy and precision has also been reported after regular peak flowmeter use. 32 Submaximal effort during PEF maneuver, supramaximal flow transients occurring early during a forced expiration, and PEF maneuver-induced bronchospasm are phenomena that may account for some of the discrepancies between PEF and FEV 1 values. It is clear from these results that if international guidelines are followed and PEF% is used as a surrogate for FEV 1 %, then severity of obstruction may be wrongly categorized in a large proportion of patients. The impact of use of PEF on categorization of severity of stable asthma was reported in an earlier study, 18 in which the categorization using PEF% and FEV 1 % was concordant in only one half of the patients. Misclassification was particularly evident in patients with severe asthma. Significant differences were also reported in a study 24 of patients with exacerbation of asthma. These differences are likely to be more pronounced in women and in patients with less severe airways obstruction (defined by FEV 1 %), as is evident from the results of logistic regression analysis conducted in this study. This has far-reaching implications for developing and resource-poor countries where facilities for conducting spirometry are not freely available, and physicians rely mainly on clinical features and/or PEF estimation to assess severity of airflow limitation. While our data set comprising of a large number of spirometry records does provide results that can perhaps be interpreted with greater confidence than previous studies, we are aware of certain inadequacies. The major limitation of our work is its retrospective nature, because of which we are unable to provide results separately for patients with asthma and COPD, or provide exact data regarding acceptability/ repeatability goals of individual spirometry maneuvers. Moreover, our results remain strictly applicable to only the kind of patient population investigated at our pulmonary function laboratory and may not be generalized to other sets of patients. We therefore suggest that until such time that more data are available, assumptions of parity between PEF% and FEV 1 % must be avoided in assessment of patients with obstructive airway disease. In case spirometry is not available, PEF measurements can be performed for broad assessment, but patients should not be categorized as having mild, moderate, or severe obstruction based on these results. References 1 Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26: American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: Eaton T, Withy S, Garrett JE, et al. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999; 116: Walters JA, Hansen E, Mudge P, et al. Barriers to the use of spirometry in general practice. Aust Fam Physician 2005; 34: Hansen EF, Vestbo J, Phanareth K, et al. Peak flow as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: Jackson H, Hubbard R. Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey. BMJ 2003; 327: Llewellin P, Sawyer G, Lewis S, et al. The relationship between FEV 1 and PEF in the assessment of the severity of airways obstruction. Respirology 2002; 7: National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma: expert panel report 2. Bethesda, MD: National Institute of Health, British guideline on the management of asthma. Thorax 2003; 58(suppl 1):i1 i94 11 National Institutes of Health, National Heart, Lung, and Blood Institute. Update of the NHLBI/WHO Workshop Report: global strategy for asthma management and prevention, issued January Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 2002; document No BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52(suppl 5):S1 S28 13 Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease: NHLBI/WHO workshop report. Bethesda, MD: National Heart, Lung, and Blood Institute, Harrison BD, Swarbrick ET. Peak-flow percentage in asthma [letter]. Lancet 1971; 2: Kelly CA, Gibson GJ. Relation between FEV 1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax 1988; 43: Vaughan TR, Weber RW, Tipton WR, et al. Comparison of PEFR and FEV 1 in patients with varying degrees of airway 1460 Original Research
8 obstruction: effect of modest altitude. Chest 1989; 95: Teeter JG, Bleecker ER. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 1998; 113: Sawyer G, Miles J, Lewis S, et al. Classification of asthma severity: should the international guidelines be changed? Clin Exp Allergy 1998; 28: Thiadens HA, De Bock GH, Van Houwelingen JC, et al. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV(1) in primary care patients presenting with a persistent cough? Thorax 1999; 54: Aggarwal AN, Gupta D, Jindal SK. Development of a simple computer program for spirometry interpretation. J Assoc Phys India 2002; 50: Jindal SK, Wahi PL. Pulmonary function laboratory in the tropics: needs, problems and solutions. In: Sharma OP, ed. Lung disease in the tropics. New York, NY: Marcel Dekker, 1991; Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979; 74: Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: Choi IS, Koh YI, Lim H. Peak expiratory flow rate underestimates severity of airflow obstruction in acute asthma. Korean J Intern Med 2002; 17: Emerman CL, Cydulka RK. Use of peak expiratory flow rate in emergency department evaluation of acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 1996; 27: Paggiaro PL, Moscato G, Giannini D, et al. Relationship between peak expiratory flow (PEF) and FEV 1. Eur Respir J Suppl 1997; 24:39S 41S 27 Robinson DR, Chaudhary BA, Speir WA Jr. Expiratory flow limitation in large and small airways. Arch Intern Med 1984; 144: Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force. Eur Respir J 1995; 8: American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77 S American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD, version 1.2. New York, NY: American Thoracic Society, 2004; updated Paggiaro PL, Moscato G, Giannini D. The Italian Working Group on the use of peak expiratory flow rate (PEFR) in asthma. Eur Respir Rev 1993; 314: Irvin CG, Martin RJ, Chinchilli VM, et al. Quality control of peak flow meters for multicenter clinical trials: the Asthma Clinical Research Network (ACRN). Am J Respir Crit Care Med 1997; 156: CHEST / 130 / 5/ NOVEMBER,
Relationship Between FEV1& PEF in Patients with Obstructive Airway Diseases
OBSTRUCTIVE THE IRAQI POSTGRADUATE AIRWAY MEDICAL DISEASES JOURNAL Relationship Between FEV1& PEF in Patients with Obstructive Airway Diseases Muhammed.W.AL.Obaidy *, Kassim Mhamed Sultan*,Basil Fawzi
More informationAssessment of accuracy and applicability of a new electronic peak flow meter and asthma monitor
Eur Respir J 18; 12: 45 42 DOI: 18/1.8.5 Printed in UK - all rights reserved Copyright ERS Journals Ltd 18 European Respiratory Journal ISSN - 1 Assessment of accuracy and applicability of a new electronic
More informationDifference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction
ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 4 Number 2 Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction
More informationLogistic Regression Model for Prediction of Airway Reversibility Using Peak Expiratory Flow
Original Article 2012 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran ISSN: 1735-0344 TANAFFOS Logistic Regression Model for Prediction of Airway Reversibility Using Peak Expiratory
More informationPeak Expiratory Flow Is Not a Quality Indicator for Spirometry*
Original Research PULMONARY FUNCTION TESTING Peak Expiratory Flow Is Not a Quality Indicator for Spirometry* Peak Expiratory Flow Variability and FEV 1 Are Poorly Correlated in an Elderly Population Matthew
More informationPulmonary Function Testing
In the Clinic Pulmonary Function Testing Hawa Edriss MD, Gilbert Berdine MD The term PFT encompasses three different measures of lung function: spirometry, lung volumes, and diffusion capacity. In this
More informationOriginal Contributions
Original Contributions Comparison of a New Desktop Spirometer (Spirospec) with a Laboratory Spirometer in a Respiratory Out-Patient Clinic François Swart, Macé M Schuurmans MD, Johannes C Heydenreich,
More informationUNIT TWO: OVERVIEW OF SPIROMETRY. A. Definition of Spirometry
UNIT TWO: OVERVIEW OF SPIROMETRY A. Definition of Spirometry Spirometry is a medical screening test that measures various aspects of breathing and lung function. It is performed by using a spirometer,
More informationPREDICTION EQUATIONS FOR LUNG FUNCTION IN HEALTHY, LIFE TIME NEVER-SMOKING MALAYSIAN POPULATION
Prediction Equations for Lung Function in Healthy, Non-smoking Malaysian Population PREDICTION EQUATIONS FOR LUNG FUNCTION IN HEALTHY, LIFE TIME NEVER-SMOKING MALAYSIAN POPULATION Justin Gnanou, Brinnell
More informationSpirometry is the most frequently performed. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6
Eur Respir J 2006; 27: 378 383 DOI: 10.1183/09031936.06.00036005 CopyrightßERS Journals Ltd 2006 Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/ and J. Vandevoorde*, S. Verbanck
More informationOctavian C. Ioachimescu, MD; Saiprakash B. Venkateshiah, MD; Mani S. Kavuru, MD; Kevin McCarthy, RCPT; and James K.
Estimating FVC From FEV 2 and FEV 3 * Assessment of a Surrogate Spirometric Parameter Octavian C. Ioachimescu, MD; Saiprakash B. Venkateshiah, MD; Mani S. Kavuru, MD; Kevin McCarthy, RCPT; and James K.
More informationKnowledge and Practice of Medical Doctors on Chronic Obstructive Pulmonary Disease: A Preliminary Survey from a State Hospital
ORIGINAL ARTICLE Knowledge and Practice of Medical Doctors on Chronic Obstructive Pulmonary Disease: A Preliminary Survey from a State Hospital ARM Fauzi, MRCP Kulliyah of Medicine, International Islamic
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationMeenu Singh, Joseph L. Mathew, Prabhjot Malhi, B.R. Srinivas and Lata Kumar
Comparison of Improvement in Quality of Life Score with Objective Parameters of Pulmonary Function in Indian Asthmatic Children Receiving Inhaled Corticosteroid Therapy Meenu Singh, Joseph L. Mathew, Prabhjot
More informationbehaviour are out of scope of the present review.
explained about the test, a trial may be done before recording the results. The maneuver consists initially of normal tidal breathing. The subject then inhales to maximally fill the lungs. This is followed
More informationMSRC AIR Course Karla Stoermer Grossman, MSA, BSN, RN, AE-C
MSRC AIR Course Karla Stoermer Grossman, MSA, BSN, RN, AE-C Explain the importance of objective measures in the management of asthma Explain the different types of objective measures used in the management
More informationPeak expiratory flow and the resistance of the mini-wright peak flow meter
Eur Respir J, 1996, 9, 828 833 DOI: 10.1183/09031936.96.090828 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 TECHNICAL NOTE Peak expiratory
More informationSpirometry Training Courses
Spirometry Training Courses A Position Paper of The Australian and New Zealand Society of Respiratory Science & The Thoracic Society of Australia and New Zealand At the time of the preparation of this
More informationStability of the EasyOne ultrasonic spirometer for use in general practice
Blackwell Publishing AsiaMelbourne, AustraliaRESRespirology1323-77992006 Blackwell Publishing Asia Pty Ltd2006113306310MiscellaneousCalibration of an ultrasonic spirometerjae Walters et al. Respirology
More informationLung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects
Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects Use of GOLD and ATS Criteria Connie Paladenech, RRT, RCP, FAARC Benefits and Limitations of Pulmonary Function Testing Benefits
More informationAssessing Agreement Between Methods Of Clinical Measurement
University of York Department of Health Sciences Measuring Health and Disease Assessing Agreement Between Methods Of Clinical Measurement Based on Bland JM, Altman DG. (1986). Statistical methods for assessing
More informationFVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction
Original Research PSYCHOLOGICAL TESTING FVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction Judith Cohen, MD; Dirkje S. Postma, MD, PhD; Karin Vink-Klooster;
More informationSpirometry and Flow Volume Measurements
Spirometry and Flow Volume Measurements Standards & Guidelines December 1998 To serve the public and guide the medical profession Revision Dates: December 1998 Approval Date: June 1998 Originating Committee:
More informationOffice Based Spirometry
Osteopathic Family Physician (2014)1, 14-18 Scott Klosterman, DO; Woodson Crenshaw, OMS4 Spartanburg Regional Family Medicine Residency Program; Edward Via College of Osteopathic Medicine - Virginia Campus
More informationThe recommended method for diagnosing sleep
reviews Measuring Agreement Between Diagnostic Devices* W. Ward Flemons, MD; and Michael R. Littner, MD, FCCP There is growing interest in using portable monitoring for investigating patients with suspected
More informationEVect of breathing circuit resistance on the measurement of ventilatory function
9 Department of Respiratory Medicine, The Alfred Hospital and Monash University Medical School, Melbourne, Victoria, Australia 311 D P Johns C M Ingram S Khov P D Rochford E H Walters Correspondence to:
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationRegression Equations for Spirometry in Children Aged 6 to 17 Years in Delhi Region
Short Communication Regression Equations for Spirometry in Children Aged 6 to 17 Years in Delhi Region S.K. Chhabra 1, V.K. Vijayan 2, M. Rahman 3, V. Mittal 1 and P.D. Singh 1 Departments of Cardio-respiratory
More informationDr. Akanksha Kaushal Physiotherapist, District Early Intervention Programme National Health Mission, Ambikapur, Chattisgarh, India
(Volume2, Issue6) Available online at www.ijarnd.com Evaluation of Peak Expiratory Flow Rate and Forced Expiratory Volume in One Second in Indian Children with Suspected Asthma Dr. Akanksha Kaushal Physiotherapist,
More informationUnderstanding the Basics of Spirometry It s not just about yelling blow
Understanding the Basics of Spirometry It s not just about yelling blow Carl D. Mottram, RRT RPFT FAARC Technical Director - Pulmonary Function Labs and Rehabilitation Associate Professor of Medicine -
More informationSupplementary Online Content
Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published
More informationTechnical Assessment of Spirometers Connected in Series
Technical Assessment of Spirometers Connected in Series Quentin Lefebvre, Thomas Vandergoten, Eric Derom MD PhD, Emilie Marchandise PhD, and Giuseppe Liistro MD PhD BACKGROUND: Office spirometers are now
More information/FVC ratio in children of 7-14 years of age from Western Rajasthan
Article FEV 1, FVC, FEV 1 /FVC ratio in children of 7-14 years of age from Western Rajasthan Meenakshi Sharma 1, Rambabu Sharma 2, Neelam Singh 3, Kusum Gaur 4 Abstract Background: The knowledge of pulmonary
More informationSupramaximal flow in asthmatic patients
Eur Respir J ; 19: 13 17 DOI: 1.113/93193..51 Printed in UK all rights reserved Copyright #ERS Journals Ltd European Respiratory Journal ISSN 93-193 Supramaximal flow in asthmatic patients H. Sala*, A.
More informationPFTs ACOI Board Review 2018
PFTs ACOI Board Review 2018 Thomas F. Morley, DO, MACOI, FCCP, FAASM Professor of Medicine Chairman Department of Internal Medicine Director of the Division of Pulmonary, Critical Care and Sleep Medicine
More informationStudy of dynamic lung parameters in bronchial Asthma
20; 4(1): 312-317 ISSN Print: 2394-7500 ISSN Online: 2394-5869 Impact Factor: 5.2 IJAR 20; 4(1): 312-317 www.allresearchjournal.com Received: 20-11-2017 Accepted: 21-12-2017 Dr. Madhuchhanda Pattnaik Associate
More informationSPIROMETRY TECHNIQUE. Jim Reid New Zealand
Jim Reid New Zealand The Basics Jim Reid Spirometry measures airflow and lung volumes, and is the preferred lung function test in COPD. By measuring reversibility of obstruction, it is also diagnostic
More informationSGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life
SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective
More informationTeacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology
Title: Spirometry Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology I. Measurements of Ventilation Spirometry A. Pulmonary Volumes 1. The tidal
More informationnormal and asthmatic males
Lung volume and its subdivisions in normal and asthmatic males MARGARET I. BLACKHALL and R. S. JONES1 Thorax (1973), 28, 89. Institute of Child Health, University of Liverpool, Alder Hey Children's Hospital,
More informationImportance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma
Original Article Importance of fractional exhaled nitric oxide in diagnosis of bronchiectasis accompanied with bronchial asthma Feng-Jia Chen, Huai Liao, Xin-Yan Huang, Can-Mao Xie Department of Respiratory
More informationPrediction models for peak expiratory flow rate in Indian population aged years
Research Article Prediction models for peak expiratory flow rate in Indian population aged 18 25 years Prakash Kumar Nayak 1, Sudeep Satpathy 1, Magna Manjareeka 1, Priyadarsini Samanta 1, Jayanti Mishra
More informationIndian Journal of Basic & Applied Medical Research; September 2013: Issue-8, Vol.-2, P
Original article: Study of pulmonary function in different age groups Dr.Geeta J Jagia*,Dr.Lalita Chandan Department of Physiology, Seth GS Medical College, Mumbai, India *Author for correspondence: drgrhegde@gmail.com
More informationThe role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE
The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE RHYS JEFFERIES ARTP education Learning Objectives Examine the clinical features of airways disease to distinguish
More informationPortable Spirometry During Acute Exacerbations of Asthma in Children
Journal of Asthma, 46:122 125, 2009 Copyright C 2009 Informa Healthcare USA, Inc. ISSN: 0277-0903 print / 1532-4303 online DOI: 10.1080/02770900802460522 ORIGINAL ARTICLE Portable Spirometry During Acute
More informationE. Prescott + **, P. Lange* +, J. Vestbo**
Eur Respir J, 1995, 8, 1333 1338 DOI: 10.1183/09031936.95.08081333 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Chronic mucus hypersecretion
More informationIncreased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients
Yuan et al. BMC Pulmonary Medicine 2014, 14:16 RESEARCH ARTICLE Open Access Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients Wei
More informationSpirometry: an essential clinical measurement
Shortness of breath THEME Spirometry: an essential clinical measurement BACKGROUND Respiratory disease is common and amenable to early detection and management in the primary care setting. Spirometric
More informationThe Role of Facemask Spirometry in Motor Neurone Disease (MND) Respiratory Sleep and Support Centre, Papworth Hospital NHS Trust, Papworth
The Role of Facemask Spirometry in Motor Neurone Disease (MND) Banerjee SK 1, Davies MG 1, Sharples LD 2, Smith IE 1 1 Respiratory Sleep and Support Centre, Papworth Hospital NHS Trust, Papworth Everard,
More informationPULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests
PULMONARY FUNCTION TESTING Wyka Chapter 13 Various AARC Clinical Practice Guidelines Purposes of Pulmonary Tests Is lung disease present? If so, is it reversible? If so, what type of lung disease is present?
More informationSpirometry: Introduction
Spirometry: Introduction Dr. Badri Paudel 1 2 GMC Spirometry Spirometry is a method of assessing lung function by measuring the volume of air the patient can expel from the lungs after a maximal expiration.
More informationA comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma
Eur Respir J 1999; 1: 591±596 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 1999 European Respiratory Journal ISSN 93-1936 A comparison of global questions versus health status questionnaires
More informationOver the last several years various national and
Recommendations for the Management of COPD* Gary T. Ferguson, MD, FCCP Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American
More informationImpact of the new ATS/ERS pulmonary function test interpretation guidelines
Respiratory Medicine (2007) 101, 2336 2342 Impact of the new ATS/ERS pulmonary function test interpretation guidelines Mary Elizabeth Kreider a,, Michael A. Grippi a,b a Division of Pulmonary, Allergy,
More informationWhat do pulmonary function tests tell you?
Pulmonary Function Testing Michael Wert, MD Assistant Professor Clinical Department of Internal Medicine Division of Pulmonary, Critical Care, and Sleep Medicine The Ohio State University Wexner Medical
More informationAn update on the analysis of agreement for orthodontic indices
European Journal of Orthodontics 27 (2005) 286 291 doi:10.1093/ejo/cjh078 The Author 2005. Published by Oxford University Press on behalf of the European Orthodontics Society. All rights reserved. For
More informationValue of measuring diurnal peak flow variability in the recognition of asthma: a study in general practice
Eur Respir J ; : DOI:./.. Printed in UK - all rights reserved Copyright ERS Journals Ltd European Respiratory Journal ISSN - Value of measuring diurnal peak flow variability in the recognition of asthma:
More informationDevelopment and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire*
Original Research COPD Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire* Makiko Meguro, Mphil; Elizabeth A. Barley, PhD, CPsychol; Sally Spencer,
More informationContent Indica c tion Lung v olumes e & Lung Indica c tions i n c paci c ties
Spirometry Content Indication Indications in occupational medicine Contraindications Confounding factors Complications Type of spirometer Lung volumes & Lung capacities Spirometric values Hygiene &
More informationAccuracy of Parental and Child s Reports of Changes in Symptoms of Childhood Asthma
7. Cecka JM, Gjertson DW, Terasaki PI. Pediatric renal transplantation - a review of the UNOS data. Pediatr Transplant 1997; 1: 55-64. 8. Alexander SR. Pediatric end stage renal disease. Am J Kidney Dis
More informationIs there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions?
Respiratory Medicine (2004) 98, 178 183 Is there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions? Maria Tsoumakidou, Nikolaos Tzanakis,
More informationS P I R O M E T R Y. Objectives. Objectives 2/5/2019
S P I R O M E T R Y Dewey Hahlbohm, PA-C, AE-C Objectives To understand the uses and importance of spirometry testing To perform spirometry testing including reversibility testing To identify normal and
More informationCorrelation and regression
PG Dip in High Intensity Psychological Interventions Correlation and regression Martin Bland Professor of Health Statistics University of York http://martinbland.co.uk/ Correlation Example: Muscle strength
More informationDIAGNOSTIC ACCREDITATION PROGRAM. Spirometry Quality Control Plan
DIAGNOSTIC ACCREDITATION PROGRAM Spirometry Quality Control Plan Table of Contents Introduction...1 Spirometry Definitions and Requirements...2 Spirometry Requirements... 2...4 Daily Quality Control (see
More informationSpirometry: FEVER DISEASE DIABETES HOW RELIABLE IS THIS? 9/2/2010 BUT WHAT WE PRACTICE: Spirometers are objective tools
SPIROMETRY PRINCIPLES, PROCEDURE AND QA Spirometry: Dr. Rahul Kodgule CHEST RESEARCH FOUNDATION, PUNE FEVER ISCHAEMIC HEART DISEASE DIABETES BUT WHAT WE PRACTICE: Spirometers are objective tools to diagnose
More informationAuthor's response to reviews
Author's response to reviews Title: Vital capacity and inspiratory capacitiy as additional parameters to evaluate bronchodilator response in asthmatics patients: a cross section study Authors: Karen S
More informationINFLUENCE OF MENSTRUAL CYCLE ON LUNG FUNCTIONS IN ASTHMATIC FEMALES
INFLUENCE OF MENSTRUAL CYCLE ON LUNG FUNCTIONS IN ASTHMATIC FEMALES *Dimple Arora 1, Parminder Kaur 1, Mohit Arora 2 and Urmil Gupta 3 1 Department of Physiology, Sri Guru Ramdas Institute of Medical Sciences
More informationInternational Journal of Scientific & Engineering Research, Volume 7, Issue 4, April ISSN
International Journal of Scientific & Engineering Research, Volume 7, Issue 4, April-2016 1644 Interpretation of Bronchodilator Response for Assessment of Airway Obstruction. Dr.S. meenakshi ABSTRACT:
More informationPulmonary Function Abnormalities in Patients with Metabolic Syndrome
Proceeding S.Z.P.G.M.I. Vol: 27(2): pp. 69-73, 2013. Pulmonary Function Abnormalities in Patients with Metabolic Syndrome Talha Mahmud, 1 Muhammad Siddique 2 and Anjum Naveed 3 1 Department of Pulmonology,
More informationEleven peak flow meters: a clinical evaluation
Eur Respir J 1998; 11: 188 193 DOI: 1.1183/931936.98.111188 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1998 European Respiratory Journal ISSN 93-1936 Eleven peak flow meters: a clinical
More informationAssessment of Bronchodilator Response in Various Spirometric Patterns
Original Article 2013 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran ISSN: 1735-0344 TANAFFOS Assessment of Bronchodilator Response in Various Spirometric Patterns Amir Houshang
More informationSPIROMETRY. Marijke Currie (CRFS) Care Medical Ltd Phone: Copyright CARE Medical ltd
SPIROMETRY Marijke Currie (CRFS) Care Medical Ltd Phone: 0800 333 808 Email: sales@caremed.co.nz What is spirometry Spirometry is a physiological test that measures the volume of air an individual can
More informationSpirometric protocol
Spirometric protocol Spirometry is the most common of the Pulmonary Function Test, that measures lung function, specifically the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled.
More informationSpirometry in primary care
Spirometry in primary care Wednesday 13 th July 2016 Dr Rukhsana Hussain What is spirometry? A method of assessing lung function Measures volume of air a patient can expel after a full inspiration Recorded
More informationInterpretation of Spirometry: Selection of Predicted Values and Defining Abnormality
Review Article Interpretation of Spirometry: Selection of Predicted Values and Defining Abnormality S.K. Chhabra Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi,
More informationSpirometry. Obstruction. By Helen Grim M.S. RRT. loop will have concave appearance. Flows decreased consistent with degree of obstruction.
1 2 Spirometry By Helen Grim M.S. RRT 3 4 Obstruction loop will have concave appearance. Flows decreased consistent with degree of obstruction. Volumes may be normal, but can decrease with severity of
More informationS P I R O M E T R Y. Objectives. Objectives 3/12/2018
S P I R O M E T R Y Dewey Hahlbohm, PA-C, AE-C Objectives To understand the uses and importance of spirometry testing To perform spirometry testing including reversibility testing To identify normal and
More informationQUALITY OF LIFE MEASURED BY THE ST GEORGE'S RESPIRATORY QUESTIONNAIRE AND SPIROMETRY
ERJ Express. Published on January 22, 2009 as doi: 10.1183/09031936.00116808 QUALITY OF LIFE MEASURED BY THE ST GEORGE'S RESPIRATORY QUESTIONNAIRE AND SPIROMETRY 1 Mark Weatherall, 2 Suzanne Marsh, 2 Philippa
More informationAn Evaluation of Peak Expiratory Flow Monitoring: A Comparison of Sitting Versus Standing Measurements
An Evaluation of Peak Expiratory Flow Monitoring: A Comparison of Sitting Versus Standing Measurements Emily K. McCoy, PharmD, Jeremy L. Thomas, PharmD, Rebecca S. Sowell, PharmD, Christa George, PharmD,
More informationPulmonary Function Testing. Ramez Sunna MD, FCCP
Pulmonary Function Testing Ramez Sunna MD, FCCP Lecture Overview General Introduction Indications and Uses Technical aspects Interpretation Patterns of Abnormalities When to perform a PFT 1. Evaluation
More informationClinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene
Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Emily S. Wan, John E. Hokanson, James R. Murphy, Elizabeth A. Regan, Barry J. Make, David A. Lynch, James D. Crapo, Edwin K.
More informationPULMONARY FUNCTION. VOLUMES AND CAPACITIES
PULMONARY FUNCTION. VOLUMES AND CAPACITIES The volume of air a person inhales (inspires) and exhales (expires) can be measured with a spirometer (spiro = breath, meter = to measure). A bell spirometer
More informationUsing Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern
44 The Open Respiratory Medicine Journal, 2011, 5, 44-50 Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern Open Access Imran Khalid
More informationDiagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme
ORIGINAL RESEARCH Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/management REassessment) programme 1997 2001 Mike Pearson 1 Jon G Ayres 2 Maria Sarno
More informationComparison of Different Spirometry Reference Equations in Predicting Lung Function in Sri Lankan School Children
Original Article Comparison of Different Spirometry Reference Equations in Predicting Lung Function in Sri Lankan School Children G Liyanage 1 *, BDW Jayamanne 2, Aaqiff M 3 1 Department of Paediatrics
More informationAbnormalities of plethysmographic lung volumes in asthmatic children
Respiratory Medicine (2010) 104, 966e971 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Abnormalities of plethysmographic lung volumes in asthmatic children Bruno Mahut
More informationPFT Interpretation and Reference Values
PFT Interpretation and Reference Values September 21, 2018 Eric Wong Objectives Understand the components of PFT Interpretation of PFT Clinical Patterns How to choose Reference Values 3 Components Spirometry
More informationDevelopment of a self-reported Chronic Respiratory Questionnaire (CRQ-SR)
954 Department of Respiratory Medicine, University Hospitals of Leicester, Glenfield Hospital, Leicester LE3 9QP, UK J E A Williams S J Singh L Sewell M D L Morgan Department of Clinical Epidemiology and
More informationEffect Of Byrates (Barium Sulphate) On Pulmonary Function In Byrates Mine Workers
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 01 Ver. I January. (2018), PP 46-50 www.iosrjournals.org Effect Of Byrates (Barium Sulphate)
More informationKey words: asthma; asthma classification; asthma control; asthma guidelines; asthma severity
Supplement DECREASING THE GLOBAL BURDEN OF ASTHMA Classifying Asthma* LeRoy M. Graham, MD, FCCP The most widely known method of asthma classification is the severity classification recommended in the National
More informationDiagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma
ORIGINAL RESEARCH Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma Daphne C Richter 1 James R Joubert 1 Haylene Nell
More informationMaximal expiratory flow rates (MEFR) measured. Maximal Inspiratory Flow Rates in Patients With COPD*
Maximal Inspiratory Flow Rates in Patients With COPD* Dan Stănescu, MD, PhD; Claude Veriter, MA; and Karel P. Van de Woestijne, MD, PhD Objectives: To assess the relevance of maximal inspiratory flow rates
More informationO ccupational asthma (OA) is the most commonly
58 ORIGINAL ARTICLE Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures S M Tarlo, G M Liss, K S Yeung... See end of
More informationPulmonary Function Tests. Mohammad Babai M.D Occupational Medicine Specialist
Pulmonary Function Tests Mohammad Babai M.D Occupational Medicine Specialist www.drbabai.com Pulmonary Function Tests Pulmonary Function Tests: Spirometry Peak-Flow metry Bronchoprovocation Tests Body
More informationPeak expiratory flow rate and its correlation with body surface area in healthy school children
2014; 3(4): 397-401 Available online at: www.jsirjournal.com Research Article ISSN 2320-4818 JSIR 2014; 3(4): 397-401 2014, All rights reserved Received: 11-09-2014 Accepted: 22-09-2014 Dr. K. Vijay Krishna
More informationAnnual lung function changes in young patients with chronic lung disease
Eur Respir J 22; 19: 886 891 DOI:.1183/931936.2.2492 Printed in UK all rights reserved Copyright #ERS Journals Ltd 22 European Respiratory Journal ISSN 93-1936 Annual lung function changes in young patients
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationIn patients with symptomatic COPD, desirable. Assessment of Bronchodilator Efficacy in Symptomatic COPD* Is Spirometry Useful?
Assessment of Bronchodilator Efficacy in Symptomatic COPD* Is Spirometry Useful? Denis E. O Donnell, MD, FCCP Bronchodilator therapy in COPD is deemed successful if it improves ventilatory mechanics to
More informationAnyone who smokes and/or has shortness of breath and sputum production could have COPD
COPD DIAGNOSIS AND MANAGEMENT CHECKLIST Anyone who smokes and/or has shortness of breath and sputum production could have COPD Confirm Diagnosis Presence and history of symptoms: Shortness of breath Cough
More information